1. Home
  2. NAUT vs AOMR Comparison

NAUT vs AOMR Comparison

Compare NAUT & AOMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nautilus Biotechnolgy Inc.

NAUT

Nautilus Biotechnolgy Inc.

HOLD

Current Price

$2.22

Market Cap

245.0M

Sector

Industrials

ML Signal

HOLD

AOMR

Angel Oak Mortgage REIT Inc.

HOLD

Current Price

$8.63

Market Cap

224.3M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAUT
AOMR
Founded
2016
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Real Estate Investment Trusts
Sector
Industrials
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
245.0M
224.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
NAUT
AOMR
Price
$2.22
$8.63
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$11.13
AVG Volume (30 Days)
207.9K
102.1K
Earning Date
02-26-2026
11-06-2025
Dividend Yield
N/A
14.85%
EPS Growth
N/A
N/A
EPS
N/A
0.73
Revenue
N/A
$34,705,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$17.06
P/E Ratio
N/A
$11.75
Revenue Growth
N/A
N/A
52 Week Low
$0.62
$7.36
52 Week High
$2.54
$10.88

Technical Indicators

Market Signals
Indicator
NAUT
AOMR
Relative Strength Index (RSI) 63.16 43.42
Support Level $1.86 $8.56
Resistance Level $2.05 $8.73
Average True Range (ATR) 0.12 0.14
MACD 0.00 -0.01
Stochastic Oscillator 100.00 15.48

Price Performance

Historical Comparison
NAUT
AOMR

About NAUT Nautilus Biotechnolgy Inc.

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

About AOMR Angel Oak Mortgage REIT Inc.

Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation across interest rates and credit cycles.

Share on Social Networks: